Javascript must be enabled to continue!
A Research on Profit Misappropriation by Controlling Shareholders: Taking ST Zhongzhu as an Example
View through CrossRef
This paper selects Zhongzhu Healthcare Holding Co.,Ltd (ST Zhongzhu ) as the research object, introduces the means of ST Zhongzhu’s controlling shareholders’ interest appropriation, studies the factors leading to the behaviour of interest appropriation, and puts forward targeted solution measures. This paper includes the following six parts. The first section is an introduction, combing the related literature and summarizing the background and significance of writing. The third part is the introduction of the case of ST Zhongzhu controlling shareholders encroaching on the interests of listed companies, the controlling shareholders of ST Zhongzhu encroach on the huge interests of listed companies mainly through the appropriation of funds by the related parties and the violation of the provision of guarantees for the related parties, etc., and at the same time elaborates on the negative impacts caused by this behaviour. The fourth part is the reason why the controlling shareholders of ST Zhongzhu’s interest encroachment behaviour can be realized. The fifth part is the measures to prevent the controlling shareholders’ interest encroachment, and puts forward the countermeasures to solve the encroachment of the company’s interests by the controlling shareholders of ST Zhongzhu. The sixth part is the conclusion of this paper. This paper analyses in-depth the current situation of interest encroachment in ST, and puts forward specific measures to solve the problem in view of the contributing factors. Contribute to the corresponding theoretical research.
Title: A Research on Profit Misappropriation by Controlling Shareholders: Taking ST Zhongzhu as an Example
Description:
This paper selects Zhongzhu Healthcare Holding Co.
,Ltd (ST Zhongzhu ) as the research object, introduces the means of ST Zhongzhu’s controlling shareholders’ interest appropriation, studies the factors leading to the behaviour of interest appropriation, and puts forward targeted solution measures.
This paper includes the following six parts.
The first section is an introduction, combing the related literature and summarizing the background and significance of writing.
The third part is the introduction of the case of ST Zhongzhu controlling shareholders encroaching on the interests of listed companies, the controlling shareholders of ST Zhongzhu encroach on the huge interests of listed companies mainly through the appropriation of funds by the related parties and the violation of the provision of guarantees for the related parties, etc.
, and at the same time elaborates on the negative impacts caused by this behaviour.
The fourth part is the reason why the controlling shareholders of ST Zhongzhu’s interest encroachment behaviour can be realized.
The fifth part is the measures to prevent the controlling shareholders’ interest encroachment, and puts forward the countermeasures to solve the encroachment of the company’s interests by the controlling shareholders of ST Zhongzhu.
The sixth part is the conclusion of this paper.
This paper analyses in-depth the current situation of interest encroachment in ST, and puts forward specific measures to solve the problem in view of the contributing factors.
Contribute to the corresponding theoretical research.
Related Results
Unfair prejudice in United Kingdom Company Law
Unfair prejudice in United Kingdom Company Law
It is common that the majority shareholders in a corporation take action that unfairly prejudices the minority. A majority shareholder occupies a dominant position in the decision-...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Dividend policy on controlling and non-controlling shareholders: case in Indonesia
Dividend policy on controlling and non-controlling shareholders: case in Indonesia
The purpose of this study is to examine dividend policy on both the controlling and non-controlling shareholders based on assumptions according to theories of life cycle, and free ...
Does executive directors from controlling shareholders improve corporate governance?
Does executive directors from controlling shareholders improve corporate governance?
Purpose
The existence of controlling shareholders creates a remarkable difference between the corporate governance structures of Chinese firms and those of western firms. Despite t...
Analyzing Asset Misappropriation Through the Lens of Fraud Hexagon Theory: Evaluating Whistleblowing Effectiveness in Financial and Asset Management Institutions
Analyzing Asset Misappropriation Through the Lens of Fraud Hexagon Theory: Evaluating Whistleblowing Effectiveness in Financial and Asset Management Institutions
Indonesia ranks 4th as the country with the highest number of fraud cases in the Asia-Pacific region, according to the Report to the Nations by the Association of Certified Fraud E...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Audit Committee Financial Expertise and Misappropriation of Assets
Audit Committee Financial Expertise and Misappropriation of Assets
Our study is closely related to studies by Mustafa and Meier (2006) and Chapple et al. (2007) that examined the relation between the incidence of misappropriation of assets and the...

